Arterial hypertension has a high prevalence in modern society and despite the great advances in our knowledge of its mechanism, the impact of its control is poor general. Although this complex mechanism interact, the method more frequently used of its treatment is the essay error consider phenotype variables as result of interaction of environmental genotype and respect of basic conditions such as a) effectivity, b) with out harming the quality of life, c) without propitiating the development of factors of risk d) without oppositions with the co-morbidity and e) directed to the protection of the organs target. Treatment ideally of essential hypertension patient should base on the physiopathologic mechanisms knowledge that contributes to its development. The current genetic and human genome advances integrates of physiologic and physiopathologic knowledge and population researches led us ...

Arterial hypertension has a high prevalence in modern society and despite the great advances in our knowledge of its mechanism, the impact of its control is poor general. Although this complex mechanism interact, the method more frequently used of its treatment is the essay error consider phenotype variables as result of interaction of environmental genotype and respect of basic conditions such as a) effectivity, b) with out harming the quality of life, c) without propitiating the development of factors of risk d) without oppositions with the co-morbidity and e) directed to the protection of the organs target. Treatment ideally of essential hypertension patient should base on the physiopathologic mechanisms knowledge that contributes to its development. The current genetic and human genome advances integrates of physiologic and physiopathologic knowledge and population researches led us ...

Isradipine, a new and potent antihypertensive dihydropyridine calcium antagonist, was evaluated in 132 patients (66.7% females and 33.3% males) withe the clinical diagnosis of mild to moderate hypertension, in an open multicenter study that took place in the hypertension, in an open multicenter study that took place in the hypertension clinics of several peruvian hospitals. The protocol include a wash out or diagnosis confirmation period of two weeks followed by 12 weeks of treatment with 2.5 mg isradipine twice daily.  The patients mean age was 56.7 (+-6.3), weight 66.9 kg (+- 11.0) and height 160 (+- 9.0). 30.3% of the patients had associated diseases, 86.4% had been previously treated for hypertension and 85.8% had a clinical diagnosis of arterial hypertension for more than one year.  After 90 days of treatment there was a mean decrease of 28.8 mmHg in the diastolic arterial...

Isradipine, a new and potent antihypertensive dihydropyridine calcium antagonist, was evaluated in 132 patients (66.7% females and 33.3% males) withe the clinical diagnosis of mild to moderate hypertension, in an open multicenter study that took place in the hypertension, in an open multicenter study that took place in the hypertension clinics of several peruvian hospitals. The protocol include a wash out or diagnosis confirmation period of two weeks followed by 12 weeks of treatment with 2.5 mg isradipine twice daily.  The patients mean age was 56.7 (+-6.3), weight 66.9 kg (+- 11.0) and height 160 (+- 9.0). 30.3% of the patients had associated diseases, 86.4% had been previously treated for hypertension and 85.8% had a clinical diagnosis of arterial hypertension for more than one year.  After 90 days of treatment there was a mean decrease of 28.8 mmHg in the diastolic arterial...